Shandong New Time Pharmaceutical has completed a successful FDA re-inspection
2016-08-30 16:09:42
Recently Shandong New Time Pharmaceutical has received the confirm letter and Establishment Inspection Report (EIR) issued by FDA which indicated Shandong New Time Pharmaceutical had passed FDAre-inspection
The period of FDA inspection is usually 2-3 years. Shandong New Time Pharmaceutical had passed FDA on-siteinspection in August, 2013, while receiving the FDAre-inspection in March, 2016. FDA inspectors review strictly the production sites, quality control, laboratory control, production facilities and equipments, materials, packaging and labeling in accordance with the latest cGMP.
FDA certification is the most strict and authentic in the world. The purpose of FDAre-inspection is not only the test of current cGMP level of Shandong New Time Pharmaceutical, but also the confirmation of sustainable implementation over the past two years.
August, 2016